These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12191855)

  • 61. National exposure measurements for decisions to protect public health from environmental exposures.
    Pirkle JL; Osterloh J; Needham LL; Sampson EJ
    Int J Hyg Environ Health; 2005; 208(1-2):1-5. PubMed ID: 15881972
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Toxicological significance of biological markers].
    Manno M; Sannolo N
    G Ital Med Lav Ergon; 2004; 26(4):270-7. PubMed ID: 15584434
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Screening models in occupational health practice for assessment of combined exposure to chemicals at work.
    de Mik G; Henderson PT; Bragt PC
    Int Arch Occup Environ Health; 1988; Suppl():54-62. PubMed ID: 3170001
    [No Abstract]   [Full Text] [Related]  

  • 64. Dermal exposure assessment techniques.
    Fenske RA
    Ann Occup Hyg; 1993 Dec; 37(6):687-706. PubMed ID: 8304685
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Does simplifying transport and exposure yield reliable results? An analysis of four risk assessment methods.
    Zhang Q; Crittenden JC; Mihelcic JR
    Environ Sci Technol; 2001 Mar; 35(6):1282-8. PubMed ID: 11347945
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Risks and benefits related to alimentary exposure to xenoestrogens.
    Paterni I; Granchi C; Minutolo F
    Crit Rev Food Sci Nutr; 2017 Nov; 57(16):3384-3404. PubMed ID: 26744831
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Environmental medicine, part one: the human burden of environmental toxins and their common health effects.
    Crinnion WJ
    Altern Med Rev; 2000 Feb; 5(1):52-63. PubMed ID: 10696119
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Human biomonitoring: state of the art.
    Angerer J; Ewers U; Wilhelm M
    Int J Hyg Environ Health; 2007 May; 210(3-4):201-28. PubMed ID: 17376741
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 70. ATSDR evaluation of health effects of chemicals. IV. Polycyclic aromatic hydrocarbons (PAHs): understanding a complex problem.
    Mumtaz MM; George JD; Gold KW; Cibulas W; DeRosa CT
    Toxicol Ind Health; 1996; 12(6):742-971. PubMed ID: 9050165
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Evaluation of the embryotoxic risk of industrial chemicals in pregnancy].
    Spielmann H
    Geburtshilfe Frauenheilkd; 1986 Jun; 46(6):335-9. PubMed ID: 3744001
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Risk assessment for children and other sensitive populations.
    Landrigan PJ
    Ann N Y Acad Sci; 1999; 895():1-9. PubMed ID: 10676405
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Project TENDR.
    Anderko L
    Am J Nurs; 2017 May; 117(5):61-64. PubMed ID: 28448366
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Blood-borne biomarkers and bioindicators for linking exposure to health effects in environmental health science.
    Wallace MA; Kormos TM; Pleil JD
    J Toxicol Environ Health B Crit Rev; 2016; 19(8):380-409. PubMed ID: 27759495
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Historical reconstruction of wastewater and land use impacts to groundwater used for public drinking water: exposure assessment using chemical data and GIS.
    Swartz CH; Rudel RA; Kachajian JR; Brody JG
    J Expo Anal Environ Epidemiol; 2003 Sep; 13(5):403-16. PubMed ID: 12973368
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Monitoring of aromatic amine exposures in workers at a chemical plant with a known bladder cancer excess.
    Ward EM; Sabbioni G; DeBord DG; Teass AW; Brown KK; Talaska GG; Roberts DR; Ruder AM; Streicher RP
    J Natl Cancer Inst; 1996 Aug; 88(15):1046-52. PubMed ID: 8683635
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A tiered approach for assessing children's exposure.
    Armstrong TW; Hushka LJ; Tell JG; Zaleski RT
    Environ Health Perspect; 2000 Jun; 108(6):469-74. PubMed ID: 10856018
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Principles of risk assessment for determining the safety of chemicals: recent assessment of residual solvents in drugs and di(2-ethylhexyl) phthalate.
    Hasegawa R; Koizumi M; Hirose A
    Congenit Anom (Kyoto); 2004 Jun; 44(2):51-9. PubMed ID: 15198717
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cumulative health risk assessment of 17 perfluoroalkylated and polyfluoroalkylated substances (PFASs) in the Swedish population.
    Borg D; Lund BO; Lindquist NG; Håkansson H
    Environ Int; 2013 Sep; 59():112-23. PubMed ID: 23792420
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Hormesis in precautionary regulatory culture: models preferences and the advancement of science.
    Hanekamp JC; Bast A
    Hum Exp Toxicol; 2007 Nov; 26(11):855-73. PubMed ID: 18042580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.